TP53 and lung carcinoma: However, we found that Cym A could exert its cytotoxic effects on lung cancer cells regardless of their genetic variation in the TP53 gene, as H23 cells, the TP53 mutants, were more susceptible to Cym A than other lung cancer cells harboring TP53 wild type (i.e., A549, H292, and H460).